These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24750325)

  • 1. Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: a case-control study.
    Sravan Kumar P; Ananthanarayanan PH; Rajendiran S
    J Obstet Gynaecol Res; 2014 May; 40(5):1361-7. PubMed ID: 24750325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
    Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
    Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
    Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
    Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.
    Orio F; Palomba S; Spinelli L; Cascella T; Tauchmanovà L; Zullo F; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3696-701. PubMed ID: 15292291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk in women with polycystic ovarian syndrome (PCOS).
    Bickerton AS; Clark N; Meeking D; Shaw KM; Crook M; Lumb P; Turner C; Cummings MH
    J Clin Pathol; 2005 Feb; 58(2):151-4. PubMed ID: 15677534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E; Campagna AM; Lobo RA
    Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased deiodinase activity after glucose load could lead to atherosclerosis in euthyroid women with polycystic ovary syndrome.
    Adamska A; Krentowska A; Łebkowska A; Hryniewicka J; Leśniewska M; Adamski M; Kowalska I
    Endocrine; 2019 Jul; 65(1):184-191. PubMed ID: 30945110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polycystic ovary syndrome with cardiovascular risk factors.
    Akram T; Hasan S; Imran M; Karim A; Arslan M
    Gynecol Endocrinol; 2010 Jan; 26(1):47-53. PubMed ID: 19639500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome.
    Shah AK; Yadav BK; Suri A; Shah AK
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):357-361. PubMed ID: 35439403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lipid profile and obesity in patients with polycystic ovary syndrome.
    Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R
    Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255
    [No Abstract]   [Full Text] [Related]  

  • 17. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.
    Lippi G; Arosio E; Prior M; Guidi G
    Angiology; 2001 Oct; 52(10):681-7. PubMed ID: 11666132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.